Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
- PMID: 21764467
- DOI: 10.1016/j.ijcard.2011.06.112
Anti-tumor necrosis factor α treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical